Prognostic Implications of Immune-Related Gene Pairs Signatures in Bladder Cancer

Figure 4

Development of the prognostic signature based on IRGPs in independent validation. GSE13507 dataset. (a) Distribution of risk scores based on IRGPs in bladder patients; (b) OS status of patients in different groups; (c) DSS status of patients in different groups; (d) heatmap of expression profiles of IRGPs; (e) survival analysis of OS between signature-defined risk groups; (f) time-dependent ROC curve of OS based on the 37-IRGPs prognostic signature; (g) survival analysis of DSS between signature-defined risk groups; (h) time-dependent ROC curve of DSS based on the 37-IRGPs prognostic signature.

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)